Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Variation in treatment of neonatal abstinence syndrome in US Children's Hospitals, 2004–2011

Journal of Perinatology volume 34, pages 867–872 (2014)Cite this article

Subjects

Abstract

Objective:

Neonatal abstinence syndrome (NAS) is a drug withdrawal syndrome experienced by opioid-exposed infants. There is no standard treatment for NAS and surveys suggest wide variation in pharmacotherapy for NAS. Our objective was to determine whether different pharmacotherapies for NAS are associated with differences in outcomes and to determine whether pharmacotherapy and outcome vary by hospital.

Study Design:

We used the Pediatric Health Information System Database from 2004 to 2011 to identify a cohort of infants with NAS requiring pharmacotherapy. Mixed effects hierarchical negative binomial models evaluated the association between pharmacotherapy and hospital with length of stay (LOS), length of treatment (LOT) and hospital charges, after adjusting for socioeconomic variables and comorbid clinical conditions.

Result:

Our cohort included 1424 infants with NAS from 14 children’s hospitals. Among hospitals in our sample, six used morphine, six used methadone and two used phenobarbital as primary initial treatment for NAS. In multivariate analysis, when compared with NAS patients initially treated with morphine, infants treated with methadone had shorter LOT (incidence rate ratio (IRR)=0.55; P<0.0001) and LOS (IRR=0.60; P<0.0001). Phenobarbital as a second-line agent was associated with increased LOT (IRR=2.09; P<0.0001), LOS (IRR=1.78; P<0.0001) and higher hospital charges (IRR=1.84; P<0.0001). After controlling for case-mix, hospitals varied in LOT, LOS and hospital charges.

Conclusion:

We found variation in hospital in treatment for NAS among major US children's hospitals. In analyses controlling for possible confounders, methadone as initial treatment was associated with reduced LOT and hospital stay.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Manchikanti L, Fellows B, Ailinani H, Pampati V . Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010; 13 (5): 401–435.

    PubMed  Google Scholar 

  2. Centers for Disease Control and Prevention (CDC). Drug overdose deaths—Florida, 2003-2009. MMWR Morb Mortal Wkly Rep 2011; 60 (26): 869–872.

    Google Scholar 

  3. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep 2011; 60 (43): 1487–1481.

    Google Scholar 

  4. Creanga AA, Sabel JC, Ko JY, Wasserman CR, Shapiro-Mendoza CK, Taylor P et al. Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet Gynecol 2012; 119 (5): 924–933.

    Article  Google Scholar 

  5. Epstein RA, Bobo WV, Martin PR, Morrow JA, Wang W, Chandrasekhar R et al. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol 2013; 23 (8): 498–503.

    Article  Google Scholar 

  6. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM . Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307 (18): 1934–1940.

    Article  CAS  Google Scholar 

  7. Hudak ML, Tan RC . Neonatal drug withdrawal. Pediatrics 2012; 129 (2): e540–e560.

    Article  Google Scholar 

  8. Osborn DA, Jeffery HE, Cole MJ . Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2010; (10): ) CD002059.

  9. Sarkar S, Donn SM . Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol 2006; 26 (1): 15–17.

    Article  CAS  Google Scholar 

  10. Nandakumar N, Sankar V . What is the best evidence based management of neonatal abstinence syndrome? Arch Dis Child Fetal Neonatal Ed 2006; 91 (6): F463.

    Article  CAS  Google Scholar 

  11. O’Grady M, Hopewell J, White M . Management of neonatal abstinence syndrome: a national survey and review of practice. Arch Dis Child Fetal Neonatal Ed 2009; 94: F249–F252.

    Article  Google Scholar 

  12. Moffett B, Valdes S, Kim J . Amiodarone monitoring practices in pediatric hospitals in the United States. Pediatric Cardiol 2013; 34: 1762–1766.

    Article  Google Scholar 

  13. Slaughter J, Stenger M, Reagan P . Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia. Pediatrics (Evanston) 2013; 131 (4): 716–723.

    Article  Google Scholar 

  14. McLeod L, Keren R, Gerber J, French B, Song L, Sampson N et al. Perioperative antibiotic use for spinal surgery procedures in US children's hospitals. Spine (Phila PA 1976) 2013; 38 (7): 609–616.

    Article  Google Scholar 

  15. Kaplan HC, Tabangin ME, McClendon D, Meinzen-Derr J, Margolis PA, Donovan E . Understanding variation in vitamin A supplementation among NICUs. Pediatrics (Evanston) 2010; 126 (2): e367–e373.

    Article  Google Scholar 

  16. Stenger MR, Slaughter JL, Kelleher K, Shepherd EG, Klebanoff MA, Reagan P et al. Hospital variation in nitric oxide use for premature infants. Pediatrics (Evanston) 2012; 129 (4): e945–e951.

    Article  Google Scholar 

  17. Silber JH RP, Brachet TJ, Ross RN, Bressler LJ, Even-Shoshan O, Lorch SA, Volpp KG . The Hospital Compare mortality model and the volume-outcome relationship. Health services research 2010; 45 (5): 1148–1167.

    Article  Google Scholar 

  18. Ash AS, Schwartz M, Pekoz EA . Comparing outcomes across providers In: Iezzoni L (ed). Risk Adjustment for Measuring Health Outcomes, 3 edn. Health Administration Press: Chicago, IL, USA, 2003 pp 297–333.

    Google Scholar 

  19. International Classification of Diseases, 9th Revision—Clinical Modification. American Medical Association: Chicago, IL, USA, 2008.

  20. Lainwala S, Brown E, Weinschenk N, Blackwell M, Hagadorn J . A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv Neonatal Care 2005; 5 (5): 265–272.

    Article  Google Scholar 

  21. Kraft WK, Dysart K, Greenspan JS, Gibson E, Kaltenbach K, Ehrlich ME . Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction 2011; 106 (3): 574–580.

    Article  Google Scholar 

  22. O'Mara K, Gal P, Davanzo C . Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol. Ann Pharmacother 2010; 44 (7–8): 1342–1344.

    Article  Google Scholar 

  23. Osborn DA, Jeffery HE, Cole MJ . Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2010; (10).

  24. Autret F, Mucignat V, Montgolfier-Aubron ID, Blond M, Ducrocq S, Lebas F et al. [Use of diazepam in the treatment of opioid neonatal abstinence syndrome]. Arch Pediatr 2004; 11 (11): 1308–1313.

    Article  CAS  Google Scholar 

  25. Phibbs C, Baker L, Caughey A, Danielsen B, Schmitt S, Phibbs R . Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants. N Engl J Med 2007; 356 (21): 2165–2175.

    Article  CAS  Google Scholar 

  26. Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics 2009; 123 (5): e849–e856.

    Article  Google Scholar 

  27. Coyle MG, Ferguson A, Lagasse L, Oh W, Lester B . Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr 2002; 140 (5): 561–564.

    Article  CAS  Google Scholar 

  28. Localio A, Berlin J, Have TT, Kimmel S . Adjustments for center in multicenter studies: an overview. Ann Intern Med 2001; 135 (2): 112–123.

    Article  CAS  Google Scholar 

  29. Dodd S, Bassi A, Bodger K, Williamson P . A comparison of multivariable regression models to analyse cost data. J Eval Clin Practice 2006; 12 (1): 76–86.

    Article  Google Scholar 

  30. Austin PC, Ghali WA, Tu JV . A comparison of several regression models for analysing cost of CABG surgery. Stat Med 2003; 22 (17): 2799–2815.

    Article  Google Scholar 

  31. US Bureau of Labor Statistics. Consumer Price Index. 2010 (cited on 11/5/2010]. Available at http://www.bls.gov/cpi/.

  32. American Academy of Pediatrics: Committee on Drugs. Neonatal drug withdrawal. Pediatrics 1998; 101 (6): 1079–1088.

    Google Scholar 

  33. McCormick MC, Escobar GJ, Zheng Z, Richardson DK . Place of birth and variations in management of late preterm (‘near-term’) infants. Sem Perinatol 2006; 30 (1): 44–47.

    Article  Google Scholar 

  34. Sankaran K, Chien LY, Walker R, Seshia M, Ohlsson A . Variations in mortality rates among Canadian neonatal intensive care units. Can Med Assoc J 2002; 166 (2): 173–178.

    Google Scholar 

  35. Vohr BR, Wright LL, Dusick AM, Perritt R, Poole WK, Tyson JE et al. Center differences and outcomes of extremely low birth weight infants. Pediatrics 2004; 113 (4): 781–789.

    Article  Google Scholar 

  36. Yang F, Tong X MD, Hines RN, Beard DA . Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model. J Pharmacokinet Pharmacodyn 2006; 33 (4): 485–518.

    Article  CAS  Google Scholar 

  37. Methadone. Physicians' Desk Reference 2013 (cited 12 June 2013). Available at http://www.pdr.net/drug-summary/methadone-hydrochloride-injection?druglabelid=1069&id=3154-10.

  38. Morphine Sulfate. Physicians' Desk Reference 2013 (cited 12 June 2013). Available at http://www.pdr.net/drug-summary/morphine-sulfate-oral-solution?druglabelid=1228&id=1189.

  39. Kraft WK, Nan den Anker JN . Pharmacologic management of the opioid neonatal abstinence syndrome. Pediatr Clin North Am 2012; 59 (5): 1147–1165.

    Article  Google Scholar 

  40. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363 (24): 2320–2331.

    Article  CAS  Google Scholar 

  41. Burns L, Mattick RP . Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug Alcohol Rev 2007; 26 (5): 487–492.

    Article  Google Scholar 

  42. Cleary BJ, Donnelly J, Strawbridge J, Gallagher PJ, Fahey T, Clarke M, Murphy DJ . Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction 2010; 105 (12): 2071–2084.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by the Robert Wood Johnson Foundation Clinical Scholars Program.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Vanderbilt University, Nashville, TN, USA

    S W Patrick

  2. Mildred Stahlman Division of Neonatology, Vanderbilt University, Nashville, TN, USA

    S W Patrick

  3. Vanderbilt Center for Health Services Research, Nashville, TN, USA

    S W Patrick

  4. Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA

    H C Kaplan

  5. James M Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA

    H C Kaplan

  6. Department of Pediatrics, Center for Outcomes Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA

    M Passarella & S A Lorch

  7. Department of Pediatrics and Communicable Diseases, Child Health Evaluation and Research (CHEAR) Unit, University of Michigan Health System, Ann Arbor, MI, USA

    M M Davis

  8. Gerald R. Ford School of Public Policy, University of Michigan, Ann Arbor, MI, USA

    M M Davis

  9. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA

    M M Davis

  10. Division of Neonatology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    S A Lorch

  11. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA

    S A Lorch

Authors
  1. S W Patrick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H C Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Passarella
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M M Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S A Lorch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S W Patrick.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patrick, S., Kaplan, H., Passarella, M. et al. Variation in treatment of neonatal abstinence syndrome in US Children's Hospitals, 2004–2011. J Perinatol 34, 867–872 (2014). https://doi.org/10.1038/jp.2014.114

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2014.114

This article is cited by

Search

Advanced search

Quick links